Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Gain Therapeutics (GANX) Other Non Operating Income (2020 - 2025)

Gain Therapeutics (GANX) has 6 years of Other Non Operating Income data on record, last reported at -$27382.0 in Q3 2025.

  • For Q3 2025, Other Non Operating Income rose 77.4% year-over-year to -$27382.0; the TTM value through Sep 2025 reached -$733134.0, down 140.26%, while the annual FY2024 figure was $119120.0, 127.74% up from the prior year.
  • Other Non Operating Income reached -$27382.0 in Q3 2025 per GANX's latest filing, up from -$620924.0 in the prior quarter.
  • Across five years, Other Non Operating Income topped out at $268077.0 in Q1 2024 and bottomed at -$620924.0 in Q2 2025.
  • Average Other Non Operating Income over 5 years is -$64637.4, with a median of -$27412.0 recorded in 2021.
  • Peak YoY movement for Other Non Operating Income: surged 725.73% in 2024, then tumbled 1324.92% in 2025.
  • A 5-year view of Other Non Operating Income shows it stood at -$19675.0 in 2021, then crashed by 911.13% to -$198939.0 in 2022, then crashed by 105.34% to -$408507.0 in 2023, then surged by 103.86% to $15758.0 in 2024, then tumbled by 273.77% to -$27382.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Other Non Operating Income were -$27382.0 in Q3 2025, -$620924.0 in Q2 2025, and -$100586.0 in Q1 2025.